SCHEMBL4198640

SCHEMBL4198640

CC(=COc1ccc(-c2ccccc2)cc1)C(=O)OCCCOc1cc(C)c(OCCCOC(=O)C(C)=COc2ccc(-c3ccccc3)cc2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.47
PPARA Q07869 3/20 0.47
PPARD Q03181 2/20 0.47
HDAC1 Q13547 10/20 0.40
HDAC2 Q92769 10/20 0.40
HDAC3 O15379 8/20 0.40
HDAC4 P56524 8/20 0.40
HDAC7 Q8WUI4 8/20 0.40
HDAC10 Q969S8 8/20 0.40
HDAC11 Q96DB2 8/20 0.40
HDAC8 Q9BY41 8/20 0.40
HDAC6 Q9UBN7 8/20 0.40
HDAC9 Q9UKV0 8/20 0.40
HDAC5 Q9UQL6 8/20 0.40
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
PTGER4 P35408 1/20 0.37
FFAR4 Q5NUL3 2/20 0.37
FFAR1 O14842 1/20 0.37
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197215 0.94 PPARG (0.43) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4198617 0.89 MEN1 (0.37) PPARGPPARAPPARDFFAR4POLB
SCHEMBL4197513 0.89 HDAC1 (0.49) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4188598 0.89 HDAC1 (0.49) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4194743 0.87 KDM4E (0.37) PPARGPPARAPPARDFFAR4FFAR1
SCHEMBL4184738 0.86 PPARD (0.46) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4197206 0.86 HDAC1 (0.46) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4202675 0.86 FFAR4 (0.39) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4197471 0.85 PPARG (0.41) PPARGPPARAPPARDHDAC1HDAC2
SCHEMBL4204186 0.84 PPARG (0.42) PPARGPPARAPPARDHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 PPARG 3465/4885PPARA 3322/4885PPARD 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.